🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to our Co-founder Feng Zhang on #1 in Nature Biotechnology's Top 20 translational researchers of 2020 and to our Co-founder & Wyss Institute faculty member Jim Collins on being named to @clarivate's 2021 Highly cited Researchers list! wyss.harvard.edu/news/wyss-facu…

We announce the Massachusetts Institute of Technology (MIT) Future Founders Prize Competition. Northpond is partnering w/ MIT School of Engineering and Martin Trust Center for MIT Entrepreneurship to accelerate opportunities for women founders and faculty in the venture capital ecosystem. Read about the program and women selected: news.mit.edu/2021/mit-futur…

Oravecz moved roles within Janssen earlier this year, taking on the titles of VP and global head, cell therapy platform and discovery, but has now moved out of the company altogether fiercebiotech.com/biotech/j-j-ce…

Congratulations to @Vizgen_Inc and @EmulateInc who were named as Top 10 Innovations in 2021 by The Scientist. the-scientist.com/features/2021-…

Scaling TechBio 🧬 w/ Shaan Gandhi - Director @ Northpond Ventures Check out our amazing podcast with Shaan Gandhi from Northpond Ventures here 🙌 ow.ly/t9U750H3FmB

90% of diseases cannot be treated. @totustx precisely invents covalent medicines w/ speed & efficacy to target otherwise untreatable diseases. Totus announces Series A funding, co-led by Northpond Ventures & DCVC Bio. Great story by Alex Knapp: bit.ly/totusforbes

Be sure to register for our webinar on January 6, 2022 at 11AM EST where we will discuss the scientific and economic findings of this study. Registration is now live: emulatebio.com/event/predicti… #organchips #drugdiscovery #drugsafety #cellculture #pharma #toxicology

.Personal Genome Diagnostics (PGDx) makes liquid biopsy & tissue-based genomic dx products used at hospitals & in clinical trials, bringing precision oncology testing closer to patients to help improve outcomes in cancer care. We commend PGDx on their pending acquisition by Labcorp. labcorp.com/labcorp-streng…

The pandemic drew unprecedented investment to the health sector, but the industry’s momentum really comes from tech advances and regulatory changes, insiders say. news.crunchbase.com/?p=82775

We are hiring! Interested in joining an entrepreneurial, collaborative team dedicated to building a better tomorrow? Learn more at npv.vc/careers. #northpondventures

The efficient flow of scientific data in R&D is critical to accelerating life-saving therapies to patients. @ScitaraCorp's platform enables seamless integration of data across lab workflows and operations. Scitara announces Series B funding: bit.ly/scitarab

.Vigil Neuroscience is a microglia-focused company dedicated to improving the lives of those affected by neurodegenerative diseases. Microglia are the sentinel immune cells of the brain & play a critical role in maintaining neurologic health. NASDAQ: VIGL bit.ly/vneuro

Cell and gene therapies offer life-saving treatments, but creating and distributing them is complex. Oribiotech is creating an automated approach to manufacturing, increasing throughput and decreasing costs. The company announces its Series B. bit.ly/33VloB1

Manufacturing gene therapies is a highly complex and costly process. Improving manufacturing is a way to ensure patient access to gene therapies. 64x Bio is creating a fundamental shift in manufacturing. The company announces its Series A. bit.ly/3GPbOOL

People with severe autoimmune diseases still face significant unmet treatment needs. Kyverna Therapeutics is engineering a new class of targeted cell therapies to address this challenge. Kyverna announces its Series B, led by Northpond Ventures bit.ly/34aTdy8

With its innovative functional screening platform & modern computational strategies, 1859 is reimagining the lengthy, costly, & unpredictable process of finding new small molecule drugs. It announces its Series A, co-led by Northpond Ventures & OMX_Ventures bit.ly/3uAnTEd

Chemistry, manufacturing, and controls (CMC)––a key step biopharma manufacturing––is behind in digital innovation, delaying time-to-market for therapies. To address this, QbDVision has developed a cloud-based CMC workspace. QbDVision announces Series A. prn.to/3sz2KI7

Solid tumors are hard to target & deliver a Tx response. Deficiency diseases lack working versions of proteins. WalkingFishTherapeutics's engineered B cells treat cancer & other diseases. Led by CEO Rusty Williams, Walking Fish closes its Series A. bwnews.pr/3BC4CnB

We are delighted to announce the newest member of #TeamTotus, Dr. Ovid Trifan! Dr. Trifan has helped to bring several successful oncology drugs to the market, and will advise our team as we stand on the cusp of clinical trials for TOS-358. #TotusMedicines prn.to/3p6MdKA

We proudly welcome Dr. Wei Chen to #TeamTotus as our new Chief Scientific Officer! With over 20 years of drug hunting experience, Dr. Chen will bring us one step closer to bringing new therapies to patients. #TotusMedicines prn.to/3p6MdKA